Submitted by admin on Mon, 03/14/2016 - 13:14
CBD is the second most common cannabinoid from the plant of cannabis. In contrast to THC, CBD is not psychoactive and the reduced side effects associated to its administration makes it as important as THC regarding its therapeutic properties.
Submitted by Alberto on Tue, 05/30/2017 - 11:45
Submitted by Alberto on Tue, 05/30/2017 - 11:35
2AG is a major
endocannabinoid produced from lipids in cellular membranes, mostly but not exclusively in response to cellular activity. In the brain,
endocannabinoids serve mainly as negative feedback molecules (reducing presynaptic neurotransmitter release after postsynaptic activation) keeping overall brain activity in balance.
Submitted by Alberto on Tue, 05/30/2017 - 11:14
Anandamide was the first identified endocannabinoid, named after the Sanskrit 'ananda' for inner bliss. Anandamide is produced from lipids in cellular membranes throughout the body. In the brain, anandamide is primarily involved in negative feedback, keeping brain activity in balance. In the body, anandamide is implicated in the suppression of tumour growth, pain and vomiting and the stimulation of eating.
Submitted by Alberto on Tue, 05/09/2017 - 18:14
CBDV is a non-psychoactive cannabinoid with anti-convulsant properties like its homolog CBD. It has also other potential therapeutic properties as antitumorigenic, anti-acne and antiemetic effects.
Submitted by Alberto on Thu, 05/04/2017 - 14:14
CBN is a cannabinoid with weak psycho-active properties and some therapeutic potential related to cancer, pain, ALS and eating disorders.
Submitted by Alberto on Mon, 04/10/2017 - 14:14
Submitted by admin on Mon, 03/14/2016 - 13:14
TRPV1 is part of the transient receptor potential family and is one of the non-GPCR cannabinoid receptors. TRPV1 is involved in thermoregulation and pain detection (nociception).
Submitted by admin on Mon, 03/14/2016 - 13:14
Submitted by admin on Mon, 03/14/2016 - 13:14
Parkinson's Disease is a degenerative disorder of the nervous system marked by accelerated degeneration of dopamine-producing neurons in the Substantia Nigra in the brain.
Typical symptoms of Parkinson's Disease , such as (intentional) tremor, rigidity and slowness of movement are mostly ascribed to degenerating Substantia Nigra neurons.